ClinicalTrials.Veeva

Menu
H

Hoag Memorial Hospital Presbyterian | Newport Beach, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Remdesivir
Dexamethasone
Atezolizumab
Docetaxel
Paclitaxel
Enzalutamide
Metformin
Nivolumab
Montelukast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

58 of 177 total trials

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Met...

Active, not recruiting
Metastasis From Malignant Tumor of Prostate
Drug: 177Lu-PSMA-I&T
Drug: Abiraterone with Prednisone or Enzalutamide

The goal of this clinical trial is to test CPO301, a type of drug called an antibody drug conjugate in adult patients with advanced or metastatic sol...

Enrolling
Cancer, Lung
Cancer
Drug: CPO301

This open-label, exploratory study is designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or combina...

Active, not recruiting
Metastatic Colorectal Cancer
Drug: Inavolisib
Drug: FOLFIRI

ASP1012 is a type of virus called an oncolytic virus which is used to treat some cancers.ASP1012 was changed in a laboratory to infect and kill cance...

Enrolling
Solid Tumor
Drug: ASP1012
Drug: Pembrolizumab

The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolum...

Enrolling
Ovarian Neoplasms
Melanoma
Drug: BMS-986340
Drug: BMS-936558-01

A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab ± Chemotherapy as First-Line or Second-Line Therapy in Adult Pati...

Active, not recruiting
Gastric Cancer
GastroEsophageal Cancer
Drug: Tislelizumab 200mg
Drug: DKN-01 400mg

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo
Locations recently updated

This study is designed to evaluate the safety and efficacy of ifinatamab deruxtecan (I-DXd) in combination with immune checkpoint inhibitor (ICI) ate...

Enrolling
Extensive Stage-small Cell Lung Cancer
Drug: Carboplatin
Drug: Ifinatamab deruxtecan
Status recently updated

This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity...

Enrolling
Active, not recruiting
Any Solid Tumor
Colon Cancer
Drug: LOXO-292

The purpose of this study is to assess the safety, tolerability, and efficacy of BMS-986158 alone and in combination with either Ruxolitinib or Fedra...

Active, not recruiting
Myelofibrosis
Drug: Ruxolitinib
Drug: Fedratinib

The purpose of this study is to learn about the safety and how effective the study medicine (PF-07220060) plus fulvestrant is compared to the study d...

Enrolling
Advanced or Metastatic Breast Cancer
Drug: Everolimus
Drug: Fulvestrant

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called varian...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose

The purpose of this study is to learn about the safety and effects of giving vepdegestrant along with PF-07220060. Vepdegestrant is studied to see if...

Enrolling
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once d...

Enrolling
Ulcerative Colitis
Drug: ABX464
Drug: Placebo

This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinica...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: ABX464

The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical...

Enrolling
Preclinical Alzheimer's Disease
Early Preclinical Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects who are...

Enrolling
Aortic Valve Stenosis
Aortic Valve Insufficiency
Device: SAPIEN X4 THV

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects with sy...

Enrolling
Aortic Stenosis, Severe
Device: SAPIEN X4 THV

This is a research study to evaluate the safety of an investigational autologous cell product obtained from participant's own adipose tissue as a pos...

Enrolling
Alzheimer Disease
Biological: RB-ADSC

The objective of the study is to evaluate the safety and effectiveness of the HARPOON™ System in the treatment of patients with severe degenerative m...

Active, not recruiting
Mitral Regurgitation
Device: HARPOON™ Beating Heart Mitral Valve Repair System

Trial sponsors

H
Pfizer logo
S
Edwards Lifesciences logo
University of Southern California logo
ImmunityBio logo
Bristol-Myers Squibb (BMS) logo
Gilead Sciences logo
A
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems